|
Synonyms: garetosmab-grts | Pasatru® | REGN-2477 | REGN2477
garetosmab is an approved drug
Compound class:
Antibody
Comment: Garetosmab (REGN2477) is a fully human anti-activin A (INHBA) monoclonal antibody [4]. The antibody blocks signaling of activins containing the inhibin βα subunit (i.e., activins A, AB, and AC). Peptide sequence matches in a patent search suggests that garetosmab is antibody H4H10446P2 in Regeneron Pharmaceuticals' patent US9718881B2 [3].
|
| Bioactivity Comments |
| Garetosmab neutralizes activin A and reduces activin A-mediated signalling via FOP mutant ACVR1, thus reducing heterotopic ossification. |
| Selectivity at ligand targets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||